During the past decade, Green Bay Oncology-Manistique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Green Bay Oncology-Manistique" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Green Bay Oncology-Manistique" are "Fallopian Tube Transitional Cell Carcinoma" (2 trials), "Ovarian Transitional Cell Carcinoma" (2 trials), "Acinar Cell Carcinoma" (1 trials), "Adenoid Cystic Carcinoma" (1 trials) and "Adrenal Cortical Carcinoma" (1 trials). Many other conditions were trialed in "Green Bay Oncology-Manistique" in a lesser frequency.

Most popular intervention types in "Green Bay Oncology-Manistique" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (1 trials), "Carboplatin" (1 trials), "Cediranib Maleate" (1 trials), "Gemcitabine" (1 trials) and "Gemcitabine Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Green Bay Oncology-Manistique" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Green Bay Oncology-Manistique". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Green Bay Oncology-Manistique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Green Bay Oncology-Manistique, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".